G-CSF plus azacitidine versus azacitidine alone for patients with high-risk myelodysplastic syndrome: academic, open label, randomized trial.
Tomáš StopkaLubomír MinaříkNina DusilkováMichal PeštaVojtěch KulvaitMartin ŠpačekZuzana ZemanováMarta KalousováAnna JonášováPublished in: Blood cancer journal (2022)
GA trial is registered under EudraCT#: 2013-001639-38.